neoX Biotech
Industry
- Pharmaceuticals
- Biotechnology
- Digital Health
- Artificial Intelligence
See more in Biomedtracker
Latest on neoX Biotech
Scrip
• By Dexter Jie Yan
Multiple Chinese developers of antibody-drug conjugates (ADCs) are now turning their focus to bispecific candidates based on different target combinations as they look to diversify their expertise in
Scrip
• By Jung Won Shin, Joseph Haas, and Ian Haydock
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. GC Pharma, Speragen To Co-Develop SSADH